Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PTBP1 is a potential indicator of disease progression in acute myeloid leukemia.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research - 1 Dec 2024

Xing Lina, Guo Xuefei, Zhang Xiaolei, Wang Ying, He Feng, Ren Jinhai

Abstract excerpt

This study aimed to verify a novel potential indicator of disease progression in acute myeloid leukemia (AML) patients. Bone marrow samples were collected from 27 AML patients and 27 controls without hematological malignancies. Polypyrimidine tract-binding protein 1 (PTBP1) expression in bone marrow samples was measured, and the association of PTBP1 with the French-American-British (FAB) classification,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Heterogeneous-Nuclear Ribonucleoproteins

Share to Leukemia, Myeloid, Acute

Share to Polypyrimidine Tract-Binding Protein

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 39080831
DOI: 10.1177/10815589241264783

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PTBP1 is a potential indicator of disease progression in acute myeloid leukemia.PMID 39080831Read ↗

Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapySemantic proximity Read ↗

TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.Semantic proximity Read ↗

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia.Semantic proximity Read ↗

High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid LeukemiaSemantic proximity Read ↗

A novel hierarchical prognostic model of AML solely based on molecular mutations.Semantic proximity Read ↗

PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid LeukemiaSemantic proximity Read ↗

SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.Semantic proximity Read ↗

New prognostic markers in acute myeloid leukemia: perspective from the clinic.Semantic proximity Read ↗

Potentiality of Protein phosphatase Mg2+ /Mn2+ dependent 1D as a biomarker for predicting prognosis in acute myeloid leukemia patients.Semantic proximity Read ↗

MiR-10a-5p regulates proliferation, apoptosis and cell cycle of NPM1-mutated acute myeloid leukemia cells by targeting SHANK3Semantic proximity Read ↗

[Prognostic impact of WT1 mutations in patients with acute myeloid leukemia].Semantic proximity Read ↗

BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.